Friday, June 17, 2016

Orbus Therapeutics Granted Orphan Drug Designation by European Medicines Agency for Late-Stage Brain Cancer Drug

… glioma, a rare form of brain cancer. In addition to the EMA … medical need in treating life-threatening brain cancers,” said Bob Myers, Co-Founder and …

No comments:

Post a Comment